If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
13th Oct 20175:52 pmRNSTransaction in Own Shares
10th Oct 201710:34 amRNSNet Asset Value(s)
6th Oct 20175:19 pmRNSTransaction in Own Shares
5th Oct 20172:55 pmRNSHolding(s) in Company
4th Oct 201710:39 amRNSNet Asset Value(s)
3rd Oct 20176:07 pmRNSHolding(s) in Company
26th Sep 201712:19 pmRNSSuccession Planning Update
26th Sep 201711:06 amRNSDirector's Other Directorship
26th Sep 201710:33 amRNSNet Asset Value(s)
22nd Sep 20175:23 pmRNSTransaction in Own Shares
22nd Sep 20173:44 pmRNSHalf-year Report
19th Sep 201710:38 amRNSNet Asset Value(s)
15th Sep 20175:31 pmRNSTransaction in Own Shares
12th Sep 201710:22 amRNSNet Asset Value(s)
6th Sep 20174:21 pmRNSHolding(s) in Company
6th Sep 20174:18 pmRNSHolding(s) in Company
6th Sep 201710:24 amRNSNet Asset Value(s)
5th Sep 20173:17 pmRNSHolding(s) in Company
31st Aug 20175:22 pmRNSEstimated Creditor Interests
29th Aug 201712:51 pmRNSNet Asset Value(s)
25th Aug 201712:59 pmRNSEstimated Creditors Interest
25th Aug 201712:57 pmRNSNet Asset Value(s)
22nd Aug 201711:11 amRNSNet Asset Value(s)
21st Aug 201710:26 amRNSDirector's Other Directorship
15th Aug 201711:23 amRNSNet Asset Value(s)
11th Aug 20175:07 pmRNSTransaction in Own Shares
8th Aug 201710:14 amRNSNet Asset Value(s)
3rd Aug 20172:25 pmRNSNet Asset Value(s)
31st Jul 20175:07 pmRNSInvestor Communication from AllBlue Limited
28th Jul 20173:37 pmRNSEstimated Creditor Interests
28th Jul 20173:30 pmRNSNet Asset Value(s)
25th Jul 201711:07 amRNSNet Asset Value(s)
19th Jul 20172:59 pmRNSResult of AGM
18th Jul 201712:53 pmRNSNet Asset Value(s)
11th Jul 20171:13 pmRNSNet Asset Value(s)
7th Jul 20179:57 amRNSConfirmation of AllBlue Proceeds Received
6th Jul 201710:14 amRNSNet Asset Value(s)
27th Jun 20179:33 amRNSNet Asset Value(s)
23rd Jun 20175:27 pmRNSTransaction in Own Shares
22nd Jun 201712:11 pmRNSEstimated Creditor Interests
22nd Jun 201712:10 pmRNSNet Asset Value(s)
20th Jun 201712:29 pmRNSNet Asset Value(s)
16th Jun 20175:17 pmRNSTransaction in Own Shares
16th Jun 201712:03 pmRNSHolding(s) in Company
14th Jun 201712:07 pmRNSHolding(s) in Company
13th Jun 201712:20 pmRNSNet Asset Value(s)
8th Jun 20174:26 pmRNSHolding(s) in Company
7th Jun 201711:39 amRNSNet Asset Value(s)
6th Jun 201711:51 amRNSNet Asset Value(s)
6th Jun 201711:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.